Your browser doesn't support javascript.
loading
HIV Infection Status as a Predictor of Hepatitis C Virus RNA Testing in Primary Care.
Yartel, Anthony K; Morgan, Rebecca L; Rein, David B; Ann Brown, Kimberly; Kil, Natalie B; Massoud, Omar I; Fallon, Michael B; Smith, Bryce D.
Afiliación
  • Yartel AK; CDC Foundation, Atlanta, Georgia. Electronic address: jqi0@cdc.gov.
  • Morgan RL; Division of Viral Hepatitis, CDC, Atlanta, Georgia.
  • Rein DB; Public Health Department, NORC at the University of Chicago, Atlanta, Georgia.
  • Ann Brown K; Department of Medicine, Henry Ford Hospital, Detroit, Michigan.
  • Kil NB; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Massoud OI; Department of Medicine, University of Alabama at Birmingham (Massoud), Birmingham, Alabama.
  • Fallon MB; Department of Internal Medicine, the University of Texas Medical School at Houston (Fallon), Houston, Texas.
  • Smith BD; Division of Viral Hepatitis, CDC, Atlanta, Georgia.
Am J Prev Med ; 49(3): 423-7, 2015 Sep.
Article en En | MEDLINE | ID: mdl-25896194
INTRODUCTION: Receipt of hepatitis C virus (HCV) RNA testing following a positive HCV antibody (anti-HCV+) test result to establish current infection is a quality indicator for HCV-related care. This study examines HIV infection status as a predictor of HCV RNA test receipt after an anti-HCV+ result in the primary care setting. METHODS: Electronic medical records of anti-HCV+ patients from a multisite retrospective study of patients aged ≥18 years who utilized one or more primary care outpatient services during 2005-2010 were analyzed in 2014. A multivariable logistic regression model examined the independent relationships between patient characteristics and receipt of HCV RNA testing. RESULTS: Among 1,115 anti-HCV+ patients, 133 (11.9%) were also HIV-positive. Of these, 77.4% (n=103) underwent HCV RNA testing to determine current infection status. By contrast, 66.7% (n=654/980) of anti-HCV+ patients who were HIV-negative received HCV RNA testing. Following multivariable adjustment, the odds of receiving HCV RNA testing were higher among anti-HCV+ patients who were also HIV-positive (AOR=1.9, 95% CI=1.2, 3.0), compared with their HIV-negative counterparts. Elevated alanine aminotransferase level was also associated with receipt of HCV RNA testing (AOR=1.9, 95% CI=1.4, 2.4). Black race was associated with decreased odds of receiving HCV RNA testing (AOR=0.7, 95% CI=0.5, 1.0). CONCLUSIONS: HIV infection status is independently associated with the likelihood of receiving HCV RNA testing following an anti-HCV+ result. One quarter of anti-HCV+ patients who were also HIV-positive and one third of their HIV-negative counterparts, respectively, did not receive testing to establish active HCV infection, which is imperative for appropriate care and treatment.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ARN Viral / Infecciones por VIH / Hepatitis C / Anticuerpos contra la Hepatitis C Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Am J Prev Med Asunto de la revista: SAUDE PUBLICA Año: 2015 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ARN Viral / Infecciones por VIH / Hepatitis C / Anticuerpos contra la Hepatitis C Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Am J Prev Med Asunto de la revista: SAUDE PUBLICA Año: 2015 Tipo del documento: Article Pais de publicación: Países Bajos